Connection
Ty Kiser to Kidney Diseases
This is a "connection" page, showing publications Ty Kiser has written about Kidney Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.030 |
|
|
|
-
Vondracek SF, Teitelbaum I, Kiser TH. Principles of Kidney Pharmacotherapy for the Nephrologist: Core Curriculum 2021. Am J Kidney Dis. 2021 09; 78(3):442-458.
Score: 0.588
-
Kiser TH, Fish DN. Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction. Pharmacotherapy. 2006 Apr; 26(4):452-60.
Score: 0.204
-
Reilly AM, Ding MX, Rower JE, Kiser TH. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations. J Clin Pharmacol. 2019 07; 59(7):997-1005.
Score: 0.124
-
Hong LT, Goolsby TA, Sherman DS, Mueller SW, Reynolds P, Cava L, Neumann R, Kiser TH. Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients. J Crit Care. 2015 Oct; 30(5):1153.e1-6.
Score: 0.097
-
Horinek EL, Kiser TH, Fish DN, MacLaren R. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions. Ann Pharmacother. 2009 Dec; 43(12):1964-71.
Score: 0.016